Cargando…

Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications

Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases worldwide. In recent years, the occurrence rate of MAFLD has been on the rise, mainly due to lifestyle changes, high-calorie diets, and imbalanced dietary structures, thereby posing a threat to human he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Gong-Jing, Yao, Fei, Lu, Wei-Peng, Xu, Hao-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401411/ https://www.ncbi.nlm.nih.gov/pubmed/37547030 http://dx.doi.org/10.4254/wjh.v15.i7.867

Ejemplares similares

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
por: Said, Imaad, et al.
Publicado: (2022)

Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
por: Oh, Joo Hyun, et al.
Publicado: (2021)

Fatty liver and alteration of the gut microbiome induced by diallyl disulfide
por: Yang, Yanhong, et al.
Publicado: (2019)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2021)

Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome
por: Mayneris-Perxachs, Jordi, et al.
Publicado: (2021)

Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
por: He, Li-Hong, et al.
Publicado: (2021)

Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases
por: Teunis, Charlotte, et al.
Publicado: (2022)

Association between metabolic status and gut microbiome in obese populations
por: Zeng, Qiang, et al.
Publicado: (2021)

Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
por: Lanthier, Nicolas, et al.
Publicado: (2022)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

Gut microbiome of migratory shorebirds: Current status and future perspectives
por: Zhang, Zheng, et al.
Publicado: (2021)

Roles of gut microbes in metabolic-associated fatty liver disease
por: Chen, Chun-Yao, et al.
Publicado: (2023)

Oral-Gut Microbiome Analysis in Patients With Metabolic-Associated Fatty Liver Disease Having Different Tongue Image Feature
por: Lu, Chenxia, et al.
Publicado: (2022)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
por: Iruzubieta, Paula, et al.
Publicado: (2020)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
por: Jennison, Erica, et al.
Publicado: (2021)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
por: Pezzino, Salvatore, et al.
Publicado: (2022)

Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
por: Jayakumar, Saumya, et al.
Publicado: (2019)

The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications
por: Szeligowski, Tomasz, et al.
Publicado: (2020)

The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment
por: Zhang, Binbin, et al.
Publicado: (2022)

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
por: Sharpton, Suzanne R., et al.
Publicado: (2018)

Current status of imaging in nonalcoholic fatty liver disease
por: Li, Qian, et al.
Publicado: (2018)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
por: Dongoran, Rachmad Anres, et al.
Publicado: (2023)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
por: Chen, Tsung-Po, et al.
Publicado: (2023)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease
por: Heshmati, Hassan Massoud
Publicado: (2021)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

Gut Microbiome and Serum Metabolome Analyses Identify Unsaturated Fatty Acids and Butanoate Metabolism Induced by Gut Microbiota in Patients With Chronic Spontaneous Urticaria
por: Wang, Detong, et al.
Publicado: (2020)

The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
por: van Best, Niels, et al.
Publicado: (2015)

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Intertwined Relationship of Mitochondrial Metabolism, Gut Microbiome and Exercise Potential
por: Imdad, Saba, et al.
Publicado: (2022)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
por: Kang, Kai, et al.
Publicado: (2021)

Xenobiotic Metabolism and Gut Microbiomes
por: Das, Anubhav, et al.
Publicado: (2016)

Links between gut microbiome composition and fatty liver disease in a large population sample
por: Ruuskanen, Matti O., et al.
Publicado: (2021)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u9kccu7njsgf8gpvqjb8h5qvte